Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

被引:14
|
作者
Ji, Kun [1 ]
Ma, Jianling [1 ]
Wang, Liangmin [1 ]
Li, Niuniu [1 ]
Dong, Shangjuan [1 ]
Shi, Liqing [1 ]
机构
[1] Beijing Univ Tradit Chinese Med, Dongfang Hosp, Dept Resp Med, Beijing 100078, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDEMIOLOGY; SURVIVAL; TRIAL;
D O I
10.1155/2020/1752387
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis. Methods. Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM. Results. A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = - 0.51, 95% CI - 0.70 to - 0.22, p < 0.001). Subgroup analysis of different study durations (3 months, >= 6 months) and comparison models (TCM vs. WM, TCM+ WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27-1.60, p = 0.352). *ere was no obvious publication bias, and the pooled results were stable according to sensitivity analysis. Conclusion. To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Efficacy of traditional Chinese medicine injections for treating idiopathic pulmonary fibrosis: A systematic review and network meta-analysis
    Huang, Shuai-yang
    Cui, Hong-sheng
    Lyu, Ming-sheng
    Huang, Gui-rui
    Hou, Dan
    Yu, Ming-xia
    PLOS ONE, 2022, 17 (07):
  • [2] Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    Wu, Qi
    Zhou, Yao
    Feng, Fan-chao
    Zhou, Xian-mei
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (10) : 778 - 784
  • [3] Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    WU Qi
    ZHOU Yao
    FENG Fan-chao
    ZHOU Xian-mei
    Chinese Journal of Integrative Medicine, 2019, (10) : 778 - 784
  • [4] Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    Qi Wu
    Yao Zhou
    Fan-chao Feng
    Xian-mei Zhou
    Chinese Journal of Integrative Medicine, 2019, 25 : 778 - 784
  • [5] Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    WU Qi
    ZHOU Yao
    FENG Fanchao
    ZHOU Xianmei
    Chinese Journal of Integrative Medicine, 2019, 25 (10) : 778 - 784
  • [6] Multiple Traditional Chinese Medicine interventions for idiopathic pulmonary fibrosis A protocol for systematic review and meta-analysis of overview
    Zhang, Hao-Yang
    Pang, Li-Jian
    Lv, Xiao-Dong
    Liu, Chuang
    Nan, Ming-Hua
    MEDICINE, 2020, 99 (39) : E22396
  • [7] Meta-Analysis of Clinical Efficacy and Safety of Ligustrazine in the Treatment of Idiopathic Pulmonary Fibrosis
    Wu, Xiaozheng
    Li, Wen
    Luo, Zhenliang
    Chen, Yunzhi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [8] Efficacy and safety of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis caused by novel coronavirus disease A protocol for Bayesian network meta-analysis
    Li, Feiran
    Wang, Guanyu
    Zhang, Wei
    Zhang, Caiqing
    MEDICINE, 2021, 100 (51) : E28282
  • [9] A systematic review and meta-analysis of the efficacy and safety of traditional Chinese medicine in the treatment of rhinosinusitis
    Huang, Zhihao
    Xuan, Xin
    Liu, Shan
    Lin, Jinglan
    Qian, Zhijun
    Chen, Lifen
    Qiu, Ruoqing
    Cai, Yanwen
    MEDICINE, 2024, 103 (48)
  • [10] Efficacy and safety of traditional Chinese medicine on treating oligomenorrhea: a systematic review and meta-analysis
    Li, Yannan
    Zhao, Guozhen
    Shi, Wei
    Zhang, Yin
    Diao, Hanlin
    Ding, Nan
    Li, Panpan
    Zhang, Fang
    Yang, Lei
    Sun, Mengyao
    Yu, Hang
    Li, Bo
    Xu, Li
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (12) : 12955 - +